Federal Register / Vol. 83, No. 110 / Thursday, June 7, 2018 / Notices 26489 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

NIMH Psychoactive Drug Screening Program 

(PDSP). 

Date: June 19, 2018. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Vinod Charles, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6151, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–1606, 

charlesvi@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: May 31, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–12176 Filed 6–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

End of the Call for Participation for 

Computational Photography Project 

for Pill Identification (C3PI) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: With the successful 

completion of the 2016 Pill Image 

Recognition Challenge, the National 

Library of Medicine (NLM) gratefully 

acknowledges the pharmaceutical 

manufacturers, re-packagers, 

wholesalers, and retail and institutional 

pharmacies that submitted prescription 

drug products for imaging as part of its 

Computational Photography Project for 

Pill Identification (C3PI). Effective 

immediately, the NLM is concluding its 

collection of digital imagery of C3PI oral 

solid dosage formulations (OSDFs), 

discontinuing the program, and is no 

longer accepting prescription drug 

products for photography. 

FOR FURTHER INFORMATION CONTACT: Any 

question regarding C3PI and its 

discontinuation should be sent to: Dr. 

Terry Yoo at splimage@nlm.nih.gov, 

301–827–4976. 

SUPPLEMENTARY INFORMATION: C3PI 

developed information infrastructure 

and computational tools for identifying 

pills from digital photographs and 

associated data. C3PI issued a Pill Image 

Recognition (PIR) computer vision 

challenge in January 2016, seeking 

software solutions for the content-based 

information retrieval of drug 

information from images submitted as 

queries. NLM quantitatively evaluated 

the resulting entries and awarded prizes 

to the winners. The findings from the 

PIR challenge were published in 

October 2016. See https://

www.ncbi.nlm.nih.gov/pmc/articles/ 

PMC5973812/. 

NLM is ending the project. No future 

prescription drug products will be 

accepted. Digital images will not be 

obtained of drug products that may have 

been submitted but not photographed as 

of the termination of this project. 

Previous NLM Imaging Initiative 

Superseded: This notice supersedes all 

prior instructions provided by 79 FR 

56381–56382 https://

www.federalregister.gov/documents/ 

2014/09/19/2014-22308/call-forparticipation-for-computationalphotography-project-for-pillidentification-c3pi, published on 

September 19, 2014. 

Dated: June 1, 2018. 

Patricia Brennan, 

Director, National Library of Medicine, 

National Institutes of Health. 

[FR Doc. 2018–12273 Filed 6–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Nursing Research; 

Notice to Close Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Nursing Research Initial Review Group. 

Date: June 21, 2018. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Weiqun Li, MD, Scientific 

Review Officer, National Institute of Nursing 

Research, National Institutes of Health, 6701 

Democracy Blvd., Suite 710, Bethesda, MD 

20892, (301) 594–5966, wli@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.361, Nursing Research, 

National Institutes of Health, HHS) 

Dated: June 1, 2018. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–12177 Filed 6–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 


sradovich on DSK3GMQ082PROD with NOTICES
26490 Federal Register / Vol. 83, No. 110 / Thursday, June 7, 2018 / Notices 

1 33 U.S.C. 1605(c). 

2 33 CFR 81.3. 

3 33 CFR 81.5. 

4 33 U.S.C. 1605(c). 

5 33 CFR 81.18. 

6 33 U.S.C. 1605(a); 33 CFR 81.9. 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Medical Imaging Investigations. 

Date: June 29, 2018. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Songtao Liu, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5118, 

Bethesda, MD 20817, 301–827–6828, 

songtao.liu@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Dermatology, Rheumatology and 

Inflammation. 

Date: July 6, 2018. 

Time: 8:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt at Olive 8, 1635 8th Avenue, 

Seattle, WA 98275. 

Contact Person: Rajiv Kumar, Ph.D., Chief, 

MOSS IRG, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 4216, MSC 7802, Bethesda, MD 

20892, 301–435–1212, kumarra@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Role of 

Microbiome in the Developmental Origins of 

Health and Disease. 

Date: July 6, 2018. 

Time: 8:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites by Hilton 

Washington DC Chevy Chase, Embassy Suites 

by Hilton Washington DC Chevy Chase, 4300 

Military Road, Washington, DC 20015. 

Contact Person: Meenakshisundar 

Ananthanarayanan, Ph.D., Scientific Review 

Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 2178, Bethesda, MD 20892, 301– 

827–6281, meena.ananthanarayanan@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR16–274/ 

275: Serious Adverse Drug Reaction 

Research. 

Date: July 6, 2018. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Alexander D Politis, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3210, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

1150, politisa@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Dermatology and Autoimmune 

Diseases. 

Date: July 6, 2018. 

Time: 1:00 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt at Olive 8, 1635 8th Avenue, 

Seattle, WA 98275. 

Contact Person: Rajiv Kumar, Ph.D., Chief, 

MOSS IRG, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 4216, MSC 7802, Bethesda, MD 

20892, 301–435–1212, kumarra@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 1, 2018. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–12174 Filed 6–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2018–0453] 

Certificate of Alternative Compliance 

for the M/V SAMANTHA S 

AGENCY: Coast Guard, DHS. 

ACTION: Notification of issuance of a 

certificate of alternative compliance. 

SUMMARY: The Coast Guard announces 

that the Chief, Prevention Division, 

Thirteenth District has issued a 

certificate of alternative compliance 

from the International Regulations for 

Preventing Collisions at Sea, 1972 (72 

COLREGS), for the M/V SAMANTHA S 

(O.N. 1283014). We are issuing this 

notice because its publication is 

required by statute. Due to the 

construction and placement of the 

towing gear, deck equipment and 

required lights, the M/V SAMANTHA S 

cannot fully comply with the light, 

shape, or sound signal provisions of the 

72 COLREGS without interfering with 

the vessel’s design and construction. 

This notification of issuance of a 

certificate of alternative compliance 

promotes the Coast Guard’s marine 

safety mission. 

DATES: The Certificate of Alternative 

Compliance was issued on May 31, 

2018. 

FOR FURTHER INFORMATION CONTACT: For 

information or questions about this 

notice call or email LT B. Luke Woods, 

Thirteenth District, U.S. Coast Guard; 

telephone 206–220–7232, email 

Bert.L.Woods@uscg.mil@uscg.mil. 

SUPPLEMENTARY INFORMATION: The 

United States is signatory to the 

International Maritime Organization’s 

International Regulations for Preventing 

Collisions at Sea, 1972 (72 COLREGS), 

as amended. The special construction or 

purpose of some vessels makes them 

unable to comply with the light, shape, 

or sound signal provisions of the 72 

COLREGS. Under statutory law 1 and 

Coast Guard regulation,2 the vessel’s 

owner, builder, operator, or agent of 

those vessels may apply for a certificate 

of alternative compliance (COAC).3 For 

vessels of special construction, the 

cognizant Coast Guard District Office 

determines whether the vessel for which 

the COAC is sought complies as closely 

as possible with the 72 COLREGS, and 

decides whether to issue the COAC 

which must specify the required 

alternative installation. If the Coast 

Guard issues a COAC, under the 

governing statute 4 and regulations,5 the 

Coast Guard must publish notice of this 

action. Once issued, a COAC remains 

valid until information supplied in the 

COAC application or the COAC terms 

become inapplicable to the vessel. 

The Chief, Prevention Division, of the 

Thirteenth Coast Guard District, U.S. 

Coast Guard, certifies that the M/V 

SAMANTHA S (O.N. 1283014) is a 

vessel of special construction or 

purpose, and that, with respect to the 

position of the sternlight, towing light 

and sidelights, it is not possible to 

comply fully with the requirements of 

the provisions enumerated in the 72 

COLREGS, without interfering with the 

normal operation, construction, or 

design of the vessel. The Chief, 

Prevention Division, of the Thirteenth 

Coast Guard District, U.S. Coast Guard 

further finds and certifies that the 

sternlight, towing light and sidelights, 

are in the closest possible compliance 

with the applicable provisions of the 72 

COLREGS.6

This notice is issued under authority 

of 33 U.S.C. 1605(c) and 33 CFR 81.18. 

Dated: May 31, 2018. 

D.L. Brown, 

Commander, U.S. Coast Guard, Acting Chief, 

Prevention Division, Thirteenth Coast Guard 

District. 

[FR Doc. 2018–12288 Filed 6–6–18; 8:45 am] 

BILLING CODE 9110–04–P 


sradovich on DSK3GMQ082PROD with NOTICES